Relationship between the Serum De Ritis Ratio and Diabetes Tests in Korean Adults Who Underwent Health Screening at a General Hospital in Gyeonggi-do
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The purpose of this study was to analyze the relationship between diabetes and liver function test results. Unlike type 2 diabetes mellitus (T2DM), hepatogenous diabetes is caused by abnormal liver function. In this study, the relationship between liver enzymes, aspartate aminotransferase (AST), alanine transaminase (ALT), and the AST/ALT ratio (De Ritis ratio), indicating liver function, and diabetes-related tests was analyzed. The results of the study showed a positive correlation between AST and glucose (r=0.14, P＜0.01), ALT and glucose (r=0.21, P＜0.01), AST and glycated hemoglobin (HbA1c) (r=0.15, P＜0.01), and ALT and HbA1c (r=0.20, P＜0.01). The De Ritis ratio showed a negative correlation with glucose (r=‒0.20, P＜0.01) and HbA1c (r=‒0.14, P＜0.01). The results of regression analysis with AST, ALT, and the De Ritis ratio as independent variables and glucose (R2=0.05) and HbA1c (R2=0.04) as dependent variables revealed that the independent variables had a statistically significant effect on the dependent variables. AST showed a lower correlation between blood glucose and glycated hemoglobin than ALT, and an increase in ALT caused a decrease in the De Ritis ratio. Therefore, the De Ritis ratio can be said to be meaningful in relation to diabetes-related tests.
Abstract
The purpose of this study was to analyze the relationship between diabetes and liver function test results. Unlike type 2 diabetes mellitus (T2DM), hepatogenous diabetes is caused by abnormal liver function. In this study, the relationship between liver enzymes, aspartate aminotransferase (AST), alanine transaminase (ALT), and the AST/ALT ratio (De Ritis ratio), indicating liver function, and diabetes-related tests was analyzed. The results of the study showed a positive correlation between AST and glucose (r=0.14, P＜0.01), ALT and glucose (r=0.21, P＜0.01), AST and glycated hemoglobin (HbA1c) (r=0.15, P＜0.01), and ALT and HbA1c (r=0.20, P＜0.01). The De Ritis ratio showed a negative correlation with glucose (r=‒0.20, P＜0.01) and HbA1c (r=‒0.14, P＜0.01). The results of regression analysis with AST, ALT, and the De Ritis ratio as independent variables and glucose (R2=0.05) and HbA1c (R2=0.04) as dependent variables revealed that the independent variables had a statistically significant effect on the dependent variables. AST showed a lower correlation between blood glucose and glycated hemoglobin than ALT, and an increase in ALT caused a decrease in the De Ritis ratio. Therefore, the De Ritis ratio can be said to be meaningful in relation to diabetes-related tests.
참고문헌 (18)
- Bhatt HB, "Fatty liver disease in diabetes mellitus", Hepatobiliary Surg Nutr, 4, pp.101~108 (2015)[DOI]
- Blendea MC, "Diabetes and chronic liver disease : etiology and pitfalls in monitoring", Clin Diabetes, 28, pp.139~144 (2010)[DOI]
- Okamura T, "Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes : a population-based longitudinal study", BMJ Open Diabetes Res Care, 8, pp.e001629~ (2020)[DOI]
- Leite NC, "Non-alcoholic fatty liver disease and diabetes : from physiopathological interplay to diagnosis and treatment", World J Gastroenterol, 20, pp.8377~8392 (2014)[DOI]
- Lee SJ, "Diabetes mellitus and non-alcoholic fatty liver disease : diagnosis and treatment", J Korean Diabetes, 22, pp.38~45 (2021)[DOI]
- Niu H, "Nonlinear relationship between AST-to-ALT ratio and the incidence of type 2 diabetes mellitus : a follow-up study", Int J Gen Med, 14, pp.8373~8382 (2021)[DOI]
- Botros M, "The de ritis ratio : the test of time", Clin Biochem Rev, 34, pp.117~130 (2013)
- "Liver function tests"[URL]
- Kumar R, "Hepatogenous diabetes : an underestimated problem of liver cirrhosis", Indian J Endocrinol Metab, 22, pp.552~559 (2018)[DOI]
- Megyesi C, "Glucose tolerance and diabetes in chronic liver disease", Lancet, 2, pp.1051~1056 (1967)[DOI]
- Orsi E, "Hepatogenous diabetes : Is it time to separate it from type 2 diabetes?", Liver Int, 37, pp.950~962 (2017)[DOI]
- McClatchey KD, "Clinical laboratory medicine", pp.288~290 (2002), Williams & Wilkins
- Chen L, "Association between aspartate aminotransferase to alanine aminotransferase ratio and incidence of type 2 diabetes mellitus in the Japanese population : a secondary analysis of a retrospective cohort study", Diabetes Metab Syndr Obes, 14, pp.4483~4495 (2021)[DOI]
- Chen W, "Elevated AST", ALT ratio is associated with all-cause mortality and cancer incident, 2022, pp.36, e24356~
- Christman AL, "Low glycated hemoglobin and liver disease in the U.S. population", Diabetes Care, 34, pp.2548~2550 (2011)[DOI]
- Al-Jameil N, "Associated liver enzymes with hyperlipidemic profile in type 2diabetes patients", Int J Clin Exp Pathol, 7, pp.4345~4349 (2014)
- Stefan N, "Non-alcoholic fatty liver disease : causes, diagnosis, cardiometabolic consequences, and treatment strategies", Lancet Diabetes Endocrinol, 7, pp.313~324 (2019)[DOI]
- Yadav R, "The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions", J Clin Diagn Res, 7, pp.1291~1294 (2013)[DOI]